Professor Rupert Payne
Professor (Clinical)
Health and Community Sciences
University of Exeter
Smeall building
St Luke's Campus
Exeter EX1 2LU
About me:
Rupert Payne is a senior academic GP and clinical pharmacologist. He undertook his medical training and PhD in Edinburgh, and subsequently held a NIHR clinical lectureship in Cambridge and clinical senior lecturer position in Bristol.
He leads a programme of applied health service research focused on improving the safety and quality of medication use in primary car. He has a particular interest in improving how we measure, evaluate and manage polypharmacy, and has methodological expertise in pharmacoepidemiology, electronic health records, and data science. He is an active member of the Exeter Collaboration for Academic Primary Care (APEx).
He is co-Chair of the Society of Academic Primary Care, and practises clinically as a GP in North Somerset.
Interests:
Rupert leads a programme of applied health service research focused on improving the safety and quality of medicines use in primary care. He has worked with a wide range of quantitative and qualitative methodologies, and has particular expertise in pharmacoepidemiology, electronic health records, and data science.
Rupert has a particular interest in improving how we measure, evaluate and manage polypharmacy. He co-authored an influential King’s Fund report on this subject, and chaired the Research and Evidence section of the recent Department of Health National Overprescribing Review. He currently leads a large NIHR-funded clinical trial (IMPPP) evaluating a complex intervention for improving the management of polypharmacy, combining pharmacist-led structure medication review, collaborative working, informatics and approaches to increase clinician engagement. Rupert is also currently developing a novel Inappropriate Polypharmacy Score to address limitations in current approaches to assessing polypharmacy.
Rupert recently led development of the Cambridge Multimorbidity Score, an increasingly widely used tool for quantifying multimorbidity using routine health records, as well as the Bristol Medication Review model, which outlines a flexible, patient-centred approach to structured medication review. He has also published on a range of other topics related to medications and health services, including deprescribing, pharmacovigilance, sustainability, continuity of care, multimorbidity, and cardiovascular disease.
Qualifications:
- MBChB (Edin)
- PhD (Edin)
- MRCGP
- FRCPE
- FBPhS
- FHEA